| Patents for A61P 35 - Antineoplastic agents (221,099) |
|---|
| 07/18/2012 | EP2475667A1 Inhibitors of jak |
| 07/18/2012 | EP2475665A1 [1,2,4]TRIAZOLO [1,5-c]PYRIMIDINE DERIVATIVES AS Hsup90 MODULATORS |
| 07/18/2012 | EP2475661A1 Sulfonamides as inhibitors of bcl-2 family proteins for the treatment of cancer |
| 07/18/2012 | EP2475659A1 4-substituted pyridin-3-yl-carboxamide compounds and methods of use |
| 07/18/2012 | EP2475653A1 Sustituted ( heteroarylmethyl ) thiohydantoins as anticancer drugs |
| 07/18/2012 | EP2475648A1 Ortho substituted pyrimidine compounds as jak inhibitors |
| 07/18/2012 | EP2475647A1 Androgen receptor antagonists and uses thereof |
| 07/18/2012 | EP2475381A2 Methods for hematopoietic precursor mobilization |
| 07/18/2012 | EP2475378A2 Methods and materials for modulating deubiquitinases and ubiquitinated polypeptides |
| 07/18/2012 | EP2475368A1 N-4 ( - ( ( 3- ( 2 -amino-4 pyrimidinyl) -2 -pyridinyl) oxy) phenyl) -4- (4-methyl-2-thienyl) -1-phthalazinamine for use in the treatment of antimitotic agent resistant cancer |
| 07/18/2012 | EP2475367A1 NOVEL INHIBITORS OF STEAROYL-CoA-DESATURASE-1 AND THEIR USES |
| 07/18/2012 | EP2475366A1 Substituted (heteroarylmethyl) thiohydantoins as anticancer drugs |
| 07/18/2012 | EP2475364A1 Cancer cell apoptosis |
| 07/18/2012 | EP2475362A2 Cancer stem cell-targeted and drug resistant cancer therapy |
| 07/18/2012 | EP2262772B1 Quinoline derivatives as axl kinase inhibitors |
| 07/18/2012 | EP2254882B1 Use of (3-trifluoromethylsulfonyl)-n-[4-methyl -3-(4-pyridin-3-yl-pyrimidin-2yl-amino)-phenyl]-benzamide against breast cancer, glioma and angiogenesis. |
| 07/18/2012 | EP1959990B1 PQS and its conjugates as adjuvants and their uses in pharmaceutical compositions |
| 07/18/2012 | EP1959957B1 Pyrimidylaminobenzamide derivatives for the treatment of neurofibromatosis |
| 07/18/2012 | EP1951046B1 Methods to enhance chemotherapy |
| 07/18/2012 | EP1869086B1 Methods and compositions for modulating and detecting wisp activity |
| 07/18/2012 | EP1711528B1 Treatment of cancer with novel anti-il 13 monoclonal antibodies |
| 07/18/2012 | EP1470148B1 Double-stranded oligonucleotides |
| 07/18/2012 | EP1432735B1 Antagonistic anti-htnfsf13b human antibodies |
| 07/18/2012 | CN1935260B Human antibodies that bind human tnfalpha |
| 07/18/2012 | CN1839202B Process for producing cytotoxic lymphocytes |
| 07/18/2012 | CN1774448B Growth factor complexes and modulation of cell migration and growth |
| 07/18/2012 | CN1753886B Process for producing acid adduct salt of polyacidic base compound |
| 07/18/2012 | CN1738636B Use of enzyme inhibitors with aminopeptidase N and/or dipeptidylpeptidase IV activities and pharmaceutical preparations produced therefrom for the therapy and prevention of dermatological diseases with seborrhoeic hyperproliferation and altered differentiation states |
| 07/18/2012 | CN1639130B Process for producing fused imidazole compound, reformatsky reagent in stable form, and process for producing the same |
| 07/18/2012 | CN1449445B Ev-vegf nucleic acids and polypeptides and methods of use |
| 07/18/2012 | CN102597779A Method for determination of sensitivity to anti-cancer ag |
| 07/18/2012 | CN102597778A Method for determination of sensitivity to anti-cancer ag |
| 07/18/2012 | CN102597762A Anticancer agent sensitivity-determining marker |
| 07/18/2012 | CN102597236A ERCC6L as target genes for cancer therapy and diagnosis |
| 07/18/2012 | CN102597223A Process for production of natural killer cells |
| 07/18/2012 | CN102597222A Method for proliferation of antigen-specific T cells |
| 07/18/2012 | CN102597004A Chimeric antibodies specific for CD151 and use thereof in the treatment of cancer |
| 07/18/2012 | CN102596977A Triptolide prodrugs |
| 07/18/2012 | CN102596969A Condensed quinolines as protein kinase modulators |
| 07/18/2012 | CN102596963A Ether derivatives of bicyclic heteroaryls |
| 07/18/2012 | CN102596962A Inhibitors of JAK |
| 07/18/2012 | CN102596960A Hydroxyl, keto, and glucuronide derivatives of 3-(4-(7h-pyrrolo[2,3-d]pyrimidin-4-yl)-1h-pyrazol-1-yl)-3-cyclopentylpropanenitrile |
| 07/18/2012 | CN102596959A Pyrrolo [1, 2-b] pyridazine derivatives as JANUS kinase inhibitors |
| 07/18/2012 | CN102596954A JAK2 inhibitors and their use for the treatment of myeloproliferative diseases and cancer |
| 07/18/2012 | CN102596953A Propane-i-sulfonic acid {3-[5-(4-chloro-phenyl)-1h-pyrrolo[2,3-b]pyridine-3-carbonyl]-2,4-difluoro-phenyl}-amide compositions and uses thereof |
| 07/18/2012 | CN102596951A Heterocyclic sulfonamide derivatives useful as mek inhibitors |
| 07/18/2012 | CN102596949A 8-azabicyclo[3.2.1]octane-8-carboxamide derivative |
| 07/18/2012 | CN102596942A Cyclic triazo sodium channel blockers |
| 07/18/2012 | CN102596937A Compounds and compositions as protein kinase inhibitors |
| 07/18/2012 | CN102596919A Aromatase inhibitor |
| 07/18/2012 | CN102596917A Disaccharin, difumaric acid, di-l-hydroxy-2-naphthoic acid and mono-benzoic acid salts of 4- (dimethylamin0)butyl 2- (4- ( (2-amino-4-methyl-6- (pentylamino) pyrimidin- 5 -yl) methyl) phenyl)acetate |
| 07/18/2012 | CN102596916A N-oxide of 3-(2,6-dichloro-3,5-dimethoxy-phenyl)-1-{6-[4-(4-ethyl-piperazin-1-yl)-phenylamino]-pyrimidin-4-yl}-1-methyl-urea |
| 07/18/2012 | CN102596910A Androgen receptor modulating compounds |
| 07/18/2012 | CN102596256A Composition for treatment of pancreatic cancer |
| 07/18/2012 | CN102596255A Gene vector |
| 07/18/2012 | CN102596245A Combination therapy of an afucosylated CD20 antibody with bendamustine |
| 07/18/2012 | CN102596233A Compositions and methods for treating hematologic cancers targeting the SIRPa - CD47 interaction |
| 07/18/2012 | CN102596223A Tumoricidal, bactericidal, or viricidal macrophage activation |
| 07/18/2012 | CN102596222A Dermaseptin B2 used as an inhibitor of the growth of a tumor |
| 07/18/2012 | CN102596209A Pharmaceutical composition containing transiently surviving CTL |
| 07/18/2012 | CN102596200A Heteroarylaminoquinolines as tgf-beta receptor kinase inhibitors |
| 07/18/2012 | CN102596197A Combination therapy for treating proliferative diseases |
| 07/18/2012 | CN102596196A Methods for inducing programmed cell death |
| 07/18/2012 | CN102596192A Use of metformin in cancer treatment and prevention |
| 07/18/2012 | CN102586437A Application of CCDC72 gene and its expression product in preparing preparation for diagnosing and treating ovarian cancer |
| 07/18/2012 | CN102586407A Application of synuclein gamma (SNCG) gene in diagnosis and hormone therapy of breast cancer |
| 07/18/2012 | CN102586377A Concentrate containing carotenoid monomer and preparation method as well as application thereof |
| 07/18/2012 | CN102586327A D24 fiber protein modified conditionally replicating adenovirus carrier with exogenous gene by one-step method and application of carrier |
| 07/18/2012 | CN102586323A Method for constructing, expressing and purifying targeted immune fusion protein |
| 07/18/2012 | CN102586298A Preparation of long-acting human vascular endothelial growth factor 165 |
| 07/18/2012 | CN102586237A Poly-nucleic acid molecule and application thereof |
| 07/18/2012 | CN102586202A Thioredoxin and preparation method and application thereof |
| 07/18/2012 | CN102586006A Method for deeply developing and comprehensively utilizing medicinal and edible plant sea buckthorn |
| 07/18/2012 | CN102585258A Gelatin embolism microsphere and preparation method and application thereof |
| 07/18/2012 | CN102585034A Method for sulfonating pectin |
| 07/18/2012 | CN102585033A Hu shaddock pectin with anti-tumor efficacy and preparation method of hu shaddock pectin |
| 07/18/2012 | CN102585029A Preparation method and application of physiologically active notoginseng polysaccharide |
| 07/18/2012 | CN102585022A Method for extracting polysaccharides from decoction dregs left after extraction of total alkaloids of sophora alopecuroides |
| 07/18/2012 | CN102585004A AEG-1 (Astrocyte Elevated Gene-1)/1E3 monoclonal antibody with high affinity |
| 07/18/2012 | CN102585003A Preparation method and application of tumor-targeted photosensitive immunoconjugate |
| 07/18/2012 | CN102585001A Anti-mn antibodies and methods of using same |
| 07/18/2012 | CN102584999A Human VEGFR-1 (Vascular Endothelial Growth Factor Receptor-1) targeting genetically engineered lymphocyte as well as preparation method and application thereof |
| 07/18/2012 | CN102584997A Single domain antibodies directed against tumour necrosis factor-alpha and uses therefor |
| 07/18/2012 | CN102584979A Polyethylene glycol (PEG) interferon lambda |
| 07/18/2012 | CN102584946A Cam binding peptide and application thereof |
| 07/18/2012 | CN102584927A Class I triterpenoid, preparation method and application thereof |
| 07/18/2012 | CN102584916A Lignan triglucoside compound and preparation method and application thereof |
| 07/18/2012 | CN102584914A Glucoside ester compound and preparation method and application thereof |
| 07/18/2012 | CN102584888A 2-carboxyl benzamido thiourea trimethyltin compound, preparation method and application |
| 07/18/2012 | CN102584875A Flavone compound containing boric acid group and application thereof |
| 07/18/2012 | CN102584841A Quinoline coumarin derivate and preparation method and application thereof |
| 07/18/2012 | CN102584830A Dihydroindene amide compounds, and medicinal composition and application thereof |
| 07/18/2012 | CN102584829A Pyrazole and pyrazine diketone derivative and application thereof |
| 07/18/2012 | CN102584828A Pyrrolidine[3,4-d]pyrimidine derivative and preparation method and application thereof |
| 07/18/2012 | CN102584809A Amion thiazolidone compound, method for preparing same and application thereof in preparing antitumor drugs |
| 07/18/2012 | CN102584780A Glaucocalyxin derivative as well as preparing method and application thereof |
| 07/18/2012 | CN102584768A 3-nitro-8-ethyoxyl-2H-chromene compound and preparation method and application thereof |
| 07/18/2012 | CN102584767A Application of 4'-methoxy-7-hydroxy isoflavone in preparation of anti-tumor drugs and preparation method of 4'-methoxy-7-hydroxy isoflavone |
| 07/18/2012 | CN102584764A 2'-chlorine-4'- nitro flavone and derivative thereof and preparation and application of 2'-chlorine-4'- nitro flavone and derivative |
| 07/18/2012 | CN102584762A Gelsemic acid derivative and preparation method and application thereof |